Life-sciences-focused venture capital firm Forbion has held a first close on €185m for its Growth Opportunities Fund, which will focus on investments at a later stage than the firm's previous vehicles in European biotech companies.
Company will now operate as Aurora Lichtwerke and was sold as part of a non-core asset divestment
Canadian GP previously owned around 20% of the listed education company
French bank BPCE mandated advisers to sell the Germany-based digital banking platform in 2018
ECI is currently investing from its ECI 11 fund, which closed on £700m on July 2018